Tiziana Life Sciences files patent application for its …
Tiziana Life Sciences files patent application for its novel coronavirus treatment technology Tiziana Life Sciences ( LON:TILS ) chairman and founder Gabriele Cerrone talks Proactive London’s Andrew Scott through the company’s update this morning which he describes as an important step in finding a solution to the current pandemic.
Tiziana Life Sciences files patent application for its …
Tiziana Life Sciences (LON:TILS) chairman and founder Gabriele Cerrone talks Proactive London’s Andrew Scott through the company’s update this morning which he describes as an important step in …
Tiziana Life Sciences
Company Has Filed Patent Application in Support of Treatment of COVID-19 Utilizing Anti-IL6R Via Inhaled Delivery . New York/London — April 9, 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for inflammatory and autoimmune diseases, announced today that it has developed investigational new …
Tiziana Life Sci PLC – Tiziana Develops Treatment For …
Tiziana Life Sciences Develops Novel Investigational Treatment For Patients Infected with COVID-19 Utilizing Direct Delivery of Anti-Interlukin-6-Receptor Monoclonal Antibodies Company Has Filed Patent Application in Support of Treatment of COVID-19 Utilizing Anti-IL6R Via Inhaled Delivery
Tiziana Lifesciences Develops Novel Investigational …
Company Has Filed Patent Application in Support of Treatment of COVID-19 Utilizing Anti-IL6R Via Inhaled Delivery. NEW YORK and LONDON, April 09, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for inflammatory and autoimmune diseases, announced today that it has developed …
Tiziana Life Sciences PLC CEO explains how its potential …
Algernon Pharmaceuticals poised for Phase 2 trial in South Korea for potential coronavirus treatment; … Health Tiziana Life Sciences files patent application for its novel… 2 weeks, 1 day ago … Health Tiziana Life Sciences files patent application for its novel coronavirus treatment technology.
Tiziana Lifesciences Develops Novel Investigational …
Company Has Filed Patent Application in Support of Treatment of COVID-19 Utilizing Anti-IL6R Via Inhaled Delivery. NEW YORK and LONDON, April 09, 2020 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc …
Investegate |Tiziana Life Sciences Announcements | Tiziana …
Tiziana Life Sciences Files Patent on Combination of Nanoparticle-Actinomycin D with Anti-Interleukin-6 Receptor Monoclonal Antibody for Treatment of Coronaviruses Combination of nanoparticle-Actinomycin D acting as an anti-viral treatment, with an anti-inflammatory agent may present a potential therapeutic option for COVID-19 patients
Enzychem Lifesciences files provisional patent for COVID …
Enzychem Lifesciences files provisional patent for COVID-19 treatment. By: … it filed a provisional patent application with the United States Patent and … to head life sciences transactions at …
Tiziana Life Sciences | SEC Filing
Tiziana Life Sciences Develops Novel Investigational Treatment For Patients Infected with COVID-19 Utilizing Direct Delivery of Anti-Interlukin-6-Receptor Monoclonal Antibodies . Company Has Filed Patent Application in Support of Treatment of COVID-19 Utilizing Anti-IL6R Via Inhaled Delivery .
